Supportive Care in Cancer

, Volume 5, Issue 1, pp 44–52

Fatigue in women treated with bone marrow transplantation for breast cancer: A comparison with women with no history of cancer

  • Danette M. Hann
  • Paul B. Jacobsen
  • Staci C. Martin
  • Lori E. Kronish
  • Lora M. Azzarello
  • Karen K. Fields
Original Article


As more individuals undergo autologous bone marrow transplantation (BMT), there is growing interest in the impact of treatment side effects on quality of life. Fatigue is a potentially disruptive treatment side effect that has not been systematically assessed following BMT. The primary aim of this study was to determine whether the severity of fatigue and its impact on quality of life is significantly greater in women who had undergone BMT for breast cancer than in women of similar age with no history of cancer. Another aim was to identify the medical and psychosocial correlates of fatigue in women who had completed BMT. A group of women treated with autologous BMT for breast cancer (n = 43; mean age = 44; mean time since BMT = 20 months) and a group of women of similar age with no history of cancer (n = 43; mean age = 46) participated in this study. Subjects completed measures of fatigue, anxiety, depression, and sleep habits. Medical data were obtained from computerized patient records. Women who had completed BMT for breast cancer reported significantly more frequent and severe fatigue than women with no cancer history. In addition, fatigue had a significantly greater impact on daily functioning and quality of life in BMT recipients than in women with no cancer history. Fatigue following BMT for breast cancer was related to both medical factors (i.e., time since BMT) and psychosocial factors (i.e., anxiety, depressive symptoms and sleep difficulties). Following BMT for breast cancer, women may experience fatigue that is worse than might “normally” be expected and can interfere with daily functioning and quality of life. Future research should focus on identifying the biological correlates of fatigue, psychological and physiological mechanisms by which fatigue is produced, and interventions to alleviate fatigue.

Key words

Fatigue Bone marrow transplantation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ahles TA, Martin JB (1992) Cancer pain: a multidimensional perspectiv. Noninvasive approaches to pain management in the terminally ill. Hospice J 8:25–48Google Scholar
  2. 2.
    Ahles TA, Tope DM, Furstenberg C, et al (1996) Psychological and neuropsychological impact of autologous bone marrow transplantation. J Clin Oncol (in press)Google Scholar
  3. 3.
    Aistairs J (1987) Fatigue in the cancer patient: a conceptual approach to a clinical problem. Oncol Nurs Forum 14:25–30Google Scholar
  4. 4.
    Andrykowski MA, Henslee PJ, Farrall MG (1989) Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 4:75–81PubMedGoogle Scholar
  5. 5.
    Baker F, Wingard JR, Cubrow B, et al (1994) Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant 13:589–596PubMedGoogle Scholar
  6. 6.
    Berkman CF, Berkman CS, Kasl S, et al (1986) Depressive symptoms in relation to physical health and functioning in the elderly. Am J Epidemiol 124:372–388PubMedGoogle Scholar
  7. 7.
    Bruera E, MacDonald RN (1988) Asthenia in patients with advanced cancer. J Pain Symptom Manage 3:9–14PubMedGoogle Scholar
  8. 8.
    Bush NE, Haberman M, Donaldson G, et al (1995) Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc Sci Med 40:479–490PubMedGoogle Scholar
  9. 9.
    Buysse DJ, Reynolds CF, Monk TH, et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. J Psychiatr Res 28:193–213Google Scholar
  10. 10.
    Cella DF, Tross S, Orav EJ, et al (1989) Mood states of patients after the diagnosis of cancer. J Psychosoc Oncol 7:45–54Google Scholar
  11. 11.
    Fields KK, Elfenbein GJ, Perkins JB, et al (1993) Two novel high dose treatment regimens for metastatic breast cancer: ifosfamide, carboplatin, plus etoposide (ICE) and mitoxantrone plus thiotepa (MITT): outcomes and toxicities. Semin Oncol 20[Suppl 6]:59–66PubMedGoogle Scholar
  12. 12.
    Fields KK, Elfenbein GJ, Perkins JB, et al (1994) High dose versus standard dose chemotherapy for the treatment of breast cancer: a review of current concepts. In: Sackstein R, Janssen W, Elfenbein G (eds) Bone marrow transplantation: foundations for the 21st century. The New York Academy of Sciences, New York, pp 288–304Google Scholar
  13. 13.
    Fields KK, Elfenbein GJ, Lazarus HM, et al (1995) Maximum tolerated doses of ifosfamide, carboplatin, and etoposide given over six days followed by autologous stem cell rescue: toxicity profile. J Clin Oncol 13:323–332PubMedGoogle Scholar
  14. 14.
    Fields K, Perkins J, Elfenbein G, et al (1995) A phase I dose escalation trial of high dose TAXOL, NOVAN-TRONE, and thioTEPA (TNT) followed by autologous stem cell rescue (ASCR): toxicity. Proc ASCO 14:322Google Scholar
  15. 15.
    Haberman M, Bush N, Young K, et al (1993) Quality of life of adult longterm survivors of bone marrow transplantation: a qualitative analysis of narrative data. Oncol Nurs Forum 20:1545–1553PubMedGoogle Scholar
  16. 16.
    Hadjistavropoulos HD, Craig KD (1994) Acute and chronic low back pain: cognitive, affective, and behavioral dimensions. J Consult Clin Psychol 62:341–349PubMedGoogle Scholar
  17. 17.
    Magni G, Caldieron C, Rigatti-Luchini S, et al (1990) Chronic musculoskeletal pain and depressive symptoms in the general population: an analysis of the 1st National Health and Nutrition Examination Survey data. Pain 43:299–307PubMedGoogle Scholar
  18. 18.
    McKenzie R, Straus SE (1995) Chronic fatigue syndrome. Adv Intern Med 40:119–153PubMedGoogle Scholar
  19. 19.
    McNair DM, Lorr M, Droppleman LF (1981) The manual for the profile of mood states. Educational and Industrial Testing Service, San DiegoGoogle Scholar
  20. 20.
    Nail LM, Winningham ML (1993) Fatigue. In: Groenwald S, Goodman M, Frogge MH, Yarbo CH (eds) Cancer nursing: principles and practice, 3rd edn. Jones and Bartlett, Boston, pp 608–619Google Scholar
  21. 21.
    Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401Google Scholar
  22. 22.
    Spielberger CD, Gorsuch RL, Lushene RD (1970) STAI: Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo AltoGoogle Scholar
  23. 23.
    Stommel M, Given BA, Given CW, et al (1993) Gender bias in the measurement properties of the Center for Epidemiologic Studies Depression Scale (CES-D). Psychiatry Res 49:239–250PubMedGoogle Scholar
  24. 24.
    Sullivan KM, Mori M, Sanders J, et al (1992) Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant 10 [Suppl 1]:127–134PubMedGoogle Scholar
  25. 25.
    Winningham ML, Nail LM, Burke MB, et al (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21:23–36PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • Danette M. Hann
    • 1
  • Paul B. Jacobsen
    • 1
  • Staci C. Martin
    • 1
  • Lori E. Kronish
    • 2
  • Lora M. Azzarello
    • 1
  • Karen K. Fields
    • 2
  1. 1.Psychosocial Oncology ProgramH. Lee Moffitt Cancer Center and Research Institute, University of South FloridaTampaUSA
  2. 2.Bone Marrow Transplantation ProgramH. Lee Moffitt Cancer Center and Research Institute, University of South FloridaTampaUSA
  3. 3.Behavioral Research CenterAmerican Cancer SocietyAtlantaUSA

Personalised recommendations